BioMARC helps advance vaccines for Department of Defense
Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded a 10-month, $4.6 million contract funded by the Department of Defense (DoD) to help develop and manufacture new vaccines to fight encephalitic viruses that cause inflammation of the brain.